Publications

2013

Brait M, Maldonado L, Noordhuis MG, Noordhuis M, Begum S, Loyo M, et al. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. PLoS One. 2013;8(9):e70878.
Liu Z, Zanata SM, Kim J, Peterson MA, Di Vizio D, Chirieac LR, et al. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene. 2013;32(13):1660-9.
Hagen JW, Schaefer JT, Magro CM. CD20+ mycosis fungoides: a report of three cases and review of the literature. Am J Dermatopathol. 2013;35(8):833-41.
Zhang Y, Shin SJ, Liu D, Ivanova E, Foerster F, Ying H, et al. ZNF365 promotes stability of fragile sites and telomeres. Cancer Discov. 2013;3(7):798-811.
Lin P-, Giannopoulou EG, Park K, Mosquera JM, Sboner A, Tewari AK, et al. Epigenomic alterations in localized and advanced prostate cancer. Neoplasia. 2013;15(4):373-83.
Antonescu CR, Le Loarer F, Mosquera J-, Sboner A, Zhang L, Chen C-, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013;52(8):775-84.
Brady N, Chuntova P, Bade LK, Schwertfeger KL. The FGF/FGFR axis as a therapeutic target in breast cancer. Expert Rev Endocrinol Metab. 2013;8(4):391-402.
Tsui JF, Weinberger JM, Kashan M, Weiss JP, Robinson BD, Blaivas JG. Bladder lipoma. J Urol. 2013;190(4):1387-8.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700